(Ludwig Institute for Cancer Research) Investigators from the Melbourne Center of the international Ludwig Institute for Cancer Research and Pacific Edge Biotchnology Ltd today reported that they have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death.